BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Marapharm Ventures Inc. Release: Venture Company Invests In Veritas Pharma Inc

  January 10, 2017

   · 

  2 min read
• FDA

  Egalet Release: Drug Company Receives FDA Approval For ARYMO ER (Morphine Sulfate) C-II, An Extended-Release Morphine Product Formulated With Abuse-Deterrent Properties For Treatment Of Chronic Pain

  January 10, 2017

   · 

  19 min read
• FDA

  Duchesnay Release: Company Is Pleased To Announce That Health Canada Has Granted Market Authorization For Mictoryl/Mictoryl Pediatric

  January 10, 2017

   · 

  3 min read
• Business

  Natera Release: Diagnostic Company Terminates NIPT Distribution Agreement With BioReference

  January 10, 2017

   · 

  4 min read
• Business

  Tempus Release: Dr. Gary Palmer Joins Company As Chief Medical Officer

  January 10, 2017

   · 

  2 min read
• Business

  MilliporeSigma Release: Biotech Expands End-To-End Biodevelopment Centers In North America, China And Europe

  January 10, 2017

   · 

  4 min read
• FDA

  Servier Canada Release: Health Canada Approves New Heart Failure Treatment LANCORA To Reduce Mortality And Hospitalizations

  January 10, 2017

   · 

  5 min read
• Drug Development

  Corvus Pharma Announces Expansion Of Renal Cell Carcinoma Cohort In Ongoing Phase I/Ib Clinical Study Of Lead Checkpoint Inhibitor CPI-444

  January 10, 2017

   · 

  7 min read
• Pharm Country

  Helius Medical Technologies Release: Company Launches Fifth Site For Pivotal Mild To Moderate Traumatic Brain Injury Clinical Trial

  January 10, 2017

   · 

  5 min read
• Drug Development

  PetLife Pharma Release: Company Reports The First Of Three Preclinical Studies In Their pre-INAD Process For Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions Across Multiple Dosing Levels

  January 10, 2017

   · 

  3 min read